Indraprastha Medical Corporation Limited

Indraprastha Medical Corporation Limited (INDRAMEDCO) is a micro-cap Healthcare company valued at ₹2,934 crore operating in Hospital on the NSE and BSE.

Recent price move

Indraprastha Medical Corporation Limited last traded at ₹322.55, modestly up 0.34% on the day.

Recent developments

On 2026-09-18, the company announced a dividend of ₹4.00 per share, ex-date. The promoter holding remained at 51.00% as of 2026-06-30, while foreign institutional holding increased by 0.33 percentage points and domestic institutional holding decreased by 0.29 percentage points in the quarter.

Financial performance

The company's business is improving, with annual revenue rising 9.3% and net profit growing 14.0% year-over-year. In the latest quarter, revenue and net profit both increased by 11.3% and 9.5% respectively compared to the same quarter a year earlier. The net profit margin widened by 0.5 percentage points to 12.4%, while return on equity remained strong at 24.8%.

Valuation multiples

The stock trades at 16.1 times earnings, a discount to the Healthcare median of 32.0, 4.46 times book value. It yields 1.1%.

Things to watch

The stock is 47.2% below its 52-week high, and the company's market cap is ₹3,110 crore, classifying it as a micro-cap. The latest price is 2.97% lower than the previous day, and the company's debt to equity ratio is 0.05, indicating almost no debt, which may limit financial flexibility.

Where it stands

The company has shown consistent revenue and profit growth over the past five years, with profit growing at 146.9% annually. The latest quarter saw continued growth in both revenue and net profit, with the net profit margin widening. The stock is currently 47.2% below its 52-week high.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.